CTRI Number |
CTRI/2022/05/042784 [Registered on: 24/05/2022] Trial Registered Prospectively |
Last Modified On: |
22/02/2024 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Drug |
Study Design |
Randomized, Parallel Group Trial |
Public Title of Study
|
Effect of Kshar Takra Basti and Ruksha Udvartana by Triphala churna in Obesity (Sthoulya) |
Scientific Title of Study
|
A comparative clinical study to evaluate the efficacy of kshar takra basti and ruksha udvartana by triphala churna in the management of sthoulya with special reference to obesity |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Dr Vinita Chandrakar |
Designation |
PG Scholar |
Affiliation |
National Institute of Ayurveda |
Address |
Room Number 111 PG seminar hall P.G. Department of Panchkarma
National Institute of Ayurveda Jaipur, Rajasthan 302002 India Madhav vilas palace Zorawar singh Gate amer road jaipur Jaipur RAJASTHAN 302002 India |
Phone |
9406303879 |
Fax |
|
Email |
cvinita02@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Dr Surendra Vedpathak |
Designation |
HOD Department of Panchakarma |
Affiliation |
National Institute of Ayurveda |
Address |
Room 114 new Panchakarma building, Panchakarma department, national institute of ayurveda Madhav vilas palace, amer road, zorawar singh gate, jaipur Jaipur RAJASTHAN 302002 India |
Phone |
7030309088 |
Fax |
|
Email |
drsurendravedpathak50@gmail.com |
|
Details of Contact Person Public Query
|
Name |
Dr Vinita Chandrakar |
Designation |
PG Scholar |
Affiliation |
National Institute of Ayurveda |
Address |
Room Number 111 PG seminar hall P.G. Department of Panchkarma
National Institute of Ayurveda Jaipur, Rajasthan 302002 India Madhav vilas palace Zorawar singh Gate amer road jaipur Jaipur RAJASTHAN 302002 India |
Phone |
9406303879 |
Fax |
|
Email |
cvinita02@gmail.com |
|
Source of Monetary or Material Support
|
National Institute of Ayurveda |
|
Primary Sponsor
|
Name |
National Institute of Ayurveda Deemed to be University |
Address |
Amer road near jorawar singh gate jaipur Rajasthan |
Type of Sponsor |
Research institution and hospital |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Vinita Chandrakar |
National Institute of Ayurveda Deemed to be University |
panchkarma OPD number 2, hospital building, NIA campus, zorawar Singh gate, amer road Jaipur Jaipur RAJASTHAN |
9406303879
cvinita02@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Institutional Ethics Committee |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: E669||Obesity, unspecified, |
|
Intervention / Comparator Agent
|
sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | 1 | Intervention Arm | Procedure | - | bastikarma/vastikarma, बसà¥à¤¤à¤¿à¤•रà¥à¤®/वसà¥à¤¤à¤¿à¤•रà¥à¤® | (Procedure Reference: Charak sootrasthana 21/21-24, Procedure details: Kshar Takra Basti via Anal route, on empty stomach (will be given according to Kala –
Basti pattern as per classical method).There will be 06 Niruha Basti with 10 Anuvasana, 01 Anuvasana will be
administer first day then each on alternate day and remaining 03 Anuvasana Basti at last. The total duration of
therapy will be for 16 days)
| 2 | Comparator Arm | Procedure | - | udvartanam, उदà¥à¤µà¤°à¥à¤¤à¤¨à¤®à¥ | (Procedure Reference: Sushrut sootra 24/51, Procedure details: Ruksha Udvartana with Triphala Churna (250gm)for 30- 45 minutes, each day in morning, till-16 days, empty stomach.) (1) Medicine Name: Tripahala , Reference: Ashtanga hridayak sootra 6/159, Route: Topical, Dosage Form: Churna/ Powder, Dose: 250(g), Frequency: od, Duration: 16 Days |
|
|
Inclusion Criteria
|
Age From |
18.00 Year(s) |
Age To |
60.00 Year(s) |
Gender |
Both |
Details |
1.Patient suffering from classical sign and symptoms of Sthoulya.(Atikshudha, Atipipasa, Daurgandhya, Nidhradhikya)
2.The patient aged between 18 to 60 years of either sex.
3.Patient willing and able to participate in this study for entire trial period.
4.BMI criteria for the selection of the patient. (Over weight, obesity-1 and 2)
5.Patient fits for Basti karma and Udvartana karma.
|
|
ExclusionCriteria |
Details |
1.Patients with hypothyroidism
2.Patients with long term steroid treatment.
3.Patients with severe hypertension.
4.Patients with evidence of renal, hepatic and cardiac involvement.
5.Patients with skin related problem like- itching, burn, rashes etc.
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
Blinding/Masking
|
Open Label |
Primary Outcome
|
Outcome |
TimePoints |
1.Change in Weight.
2.Relief in symptoms like - Atikshuda,Alasya, Atipipasa, Nidraadhikya, Daurgandhya etc.
|
16 days with one month follow-up
|
|
Secondary Outcome
|
Outcome |
TimePoints |
1.Change in Waist circumference, MAC, Skinfold Thickness.
2.Change in Morbidity score.
|
16 days with one month follow-up |
|
Target Sample Size
|
Total Sample Size="30" Sample Size from India="30"
Final Enrollment numbers achieved (Total)= "30"
Final Enrollment numbers achieved (India)="30" |
Phase of Trial
|
Phase 2/ Phase 3 |
Date of First Enrollment (India)
|
20/06/2022 |
Date of Study Completion (India) |
30/04/2023 |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Date Missing |
Estimated Duration of Trial
|
Years="0" Months="6" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Completed |
Recruitment Status of Trial (India) |
Completed |
Publication Details
|
NIL |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
|
Sthoulya is one among the most burning problem of our society because this age of machine and materialism. In our routine life physical activities are reduced and mental stress is increased. Lack of physical activities with increased intake of food, industrialization, stress during the work, various variety of the junk food eg- fast food, frozen food, bakery items, increased amount of soft drinks results in Sthoulya. Obesity is characterized to excessive accumulation of fat. In recent year urban youth are particularly prone to the life style diseases. In Ayurveda, the description about Sthoulya is available in many Samhitas various Samhitas as Sthoulya or Medoroga in Santarpanottha vikara i.e. the disease caused by overnourishment. In Charak Samhita this condition is described under the heading of Santarpanajanya vyadhi. Acharya Yoga Ratnakara and Vangsen explained under the heading of Medoroga. Acharya Chakrapani and Bhavprakash described about Sthoulya. Obesity is a leading preventable cause of death worldwide, with increasing prevelance in adults and children, and authorities view it as one of the serious public health problem of the 21st century. There is the need of the time to look into the alternative systems for the management. Therefore, with these perspectives the present trial entitled “ A comparative clinical study to evaluate the efficacy of Kshar Takra Basti and Ruksha Udvartana in the management of Sthoulya w.s.r. to obesity†has been planned. Aim :To compare the efficacy of Kshar Takra Basti and Ruksha Udvaratana by Triphala churna in the management of Sthoulya w.s.r. to obesity. Objective: 1. To restore normal development and to reduction the sign and symptom of Sthoulya. 2.To provide effective, safe and economic remedy for adult in Sthoulya. 3. To identify a safe and effective Ayurveda Treatment for Sthoulya with minimum or no recurrence. RESEARCH QUESTION:- Is there any diffrences between the efficacy of Kshar Takra Basti and Ruksh Udvartan By Triphla churna in Sthoulya with special reference to Obesity. HYPOTHESIS: - Null Hypothesis ( H0 ) -There is no diffirence in the efficacy of Kshar Takra Basti and Ruksha Udvartana by a Triphala churna in the management of Sthoulya with special reference to obesity. Alternative Hypothesis - H1 - Kshar Takra Basti has significant effect in Sthoulya with special reference to obesity. H2 - Ruksha Udvartana has significant effect in Sthoulya with special reference to obesity. LABORATORY INVESTIGATION (Before Treatment and after Treatment) : - Ø CBC, Ø Urine, Stool Examination Ø Lipid Profile | |